Back to Results
First PageMeta Content
Anabolic steroids / Androgens / Neuroendocrinology / Testosterone / Hypogonadism / Hormone replacement therapy / Endocrine system / Medicine / Endocrinology


February 25, 2014 Margaret A. Hamburg, M.D. Commissioner Food and Drug Administration Department of Health and Human Services WO 2200
Add to Reading List

Document Date: 2014-02-25 09:22:41


Open Document

File Size: 317,18 KB

Share Result on Facebook

City

Rockville / /

Company

Barón AE / M.D. / M.D. Founder / Health Research Group Michael Carome / Singh AB / /

Country

United States / Greenland / /

IndustryTerm

pharmaceutical industry / that “testosterone products / advertising campaigns / /

MedicalCondition

stroke / heart disease / non-fatal myocardial infarction / myocardial infarction / heart attacks / heart attack / hypogonadism / coronary artery disease / cardiovascular diseases / /

MedicalTreatment

chemotherapy / testosterone replacement / /

Organization

National Institute of Health / Food and Drug Administration / U.S. Public Health Service / Food and Drug Administration Department of Health and Human Services WO / American Medical Association / Food and Drug Administration Department of Health and Human Services / /

Person

Sidney Wolfe / Mayo Clin Proc / Margaret A. Hamburg / /

Position

Director Public Citizen / Commissioner / Senior Adviser Public Citizen / representative / /

Product

testosterone / /

ProvinceOrState

Maryland / /

PublishedMedium

PLoS ONE / /

Technology

chemotherapy / /

URL

http /

SocialTag